RTW INVESTMENTS, LP
Q3 2024 13F-HR Holdings
Net value change ($000)
+451,982
(7.0%)
New positions
11
Sold out positions
11
Turnover %
9.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2024
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| GERN | 200,268 | NEW |
| SYK | 143,392 | NEW |
| ARGX | 73,322 | 26.1% |
| PTGX | 61,001 | 33.3% |
| APGE | 52,588 | 49.3% |
| NTRA | 48,391 | 17.2% |
| PTCT | 48,203 | 21.3% |
| ORKA | 45,359 | NEW |
| AKRO | 42,395 | 33.3% |
| PEN | 21,065 | 15.8% |
Top Reduces (Value $000, Stocks/ETFs)
| MDGL | -113,648 | -21.2% |
| ISRG | -90,063 | -100.0% |
| RCKT | -54,125 | -14.2% |
| Merus N.V. | -38,400 | -15.6% |
| VCEL | -36,768 | -100.0% |
| FULC | -36,245 | -100.0% |
| RARE | -24,660 | -18.4% |
| Sage Therapeutics, Inc. | -19,147 | -32.2% |
| GHRS | -16,536 | -42.6% |
| KYTX | -13,895 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|